Understanding the delayed onset of action of azathioprine in IBD: are we there yet?

Gut. 2009 Mar;58(3):325-6. doi: 10.1136/gut.2008.163485.
No abstract available

Publication types

  • Comment

MeSH terms

  • Apoptosis
  • Azathioprine / pharmacokinetics
  • Azathioprine / therapeutic use*
  • Drug Design
  • Female
  • Humans
  • Immunologic Memory
  • Immunosuppressive Agents / pharmacokinetics
  • Immunosuppressive Agents / therapeutic use*
  • Inflammatory Bowel Diseases / drug therapy*
  • Male
  • T-Lymphocytes / immunology

Substances

  • Immunosuppressive Agents
  • Azathioprine